php中文网 Courses
Nov 15, 2023 · Artificial Intelligence
AI-Discovered Drug for Idiopathic Pulmonary Fibrosis Enters Late-Stage Clinical Trials
Insilico Medicine, leveraging artificial intelligence to identify a novel target and molecule for idiopathic pulmonary fibrosis, has advanced its AI-discovered drug into late-stage clinical trials, marking the first fully AI-generated pre-clinical candidate and drawing significant attention from the pharmaceutical industry.
Clinical TrialsIdiopathic Pulmonary FibrosisPharmaceutical Innovation
0 likes · 2 min read